MX362940B - Nuevo derivado de nicotinamida o la sal del mismo. - Google Patents
Nuevo derivado de nicotinamida o la sal del mismo.Info
- Publication number
- MX362940B MX362940B MX2014007785A MX2014007785A MX362940B MX 362940 B MX362940 B MX 362940B MX 2014007785 A MX2014007785 A MX 2014007785A MX 2014007785 A MX2014007785 A MX 2014007785A MX 362940 B MX362940 B MX 362940B
- Authority
- MX
- Mexico
- Prior art keywords
- salt
- nicotinamide derivative
- formulas
- pyridyl
- novel nicotinamide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Cosmetics (AREA)
Abstract
El objetivo de la presente invención es proporcionar un compuesto y una composición farmacéutica que tenga excelente actividad inhibitoria de Syk. De acuerdo a la presente invención, es proporcionado un derivado de nicotinamida representado por la siguiente fórmula (I) o una sal del mismo, (ver Fórmula) en donde R1 es un sustituyente representado por las siguientes fórmulas (II-1), (III-1), o (IV-1) (ver Fórmulas (en donde R3, R4, R5, n, y X1 tienen las mismas definiciones que aquellas descritas en la especificación), y R2 es un grupo piridilo, indazolilo, fenilo, pirazolopiridilo, bencisoxazolilo, pirimidinilo, o quinolilo, cada uno de los cuales opcionalmente tiene al menos un sustituyente.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011288205A JP5868168B2 (ja) | 2011-12-28 | 2011-12-28 | 新規なニコチンアミド誘導体またはその塩 |
PCT/JP2011/080597 WO2013099041A1 (ja) | 2011-12-28 | 2011-12-28 | 新規なニコチンアミド誘導体またはその塩 |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2014007785A MX2014007785A (es) | 2014-07-30 |
MX362940B true MX362940B (es) | 2019-02-27 |
Family
ID=48696599
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2014007785A MX362940B (es) | 2011-12-28 | 2011-12-28 | Nuevo derivado de nicotinamida o la sal del mismo. |
Country Status (22)
Country | Link |
---|---|
US (1) | US9051310B2 (es) |
EP (1) | EP2799431B1 (es) |
JP (1) | JP5868168B2 (es) |
KR (1) | KR101744607B1 (es) |
CN (1) | CN104024226B (es) |
AU (1) | AU2016202949A1 (es) |
BR (1) | BR112014016328A8 (es) |
CA (1) | CA2861202C (es) |
DK (1) | DK2799431T3 (es) |
ES (1) | ES2661444T3 (es) |
IL (1) | IL233385B (es) |
MX (1) | MX362940B (es) |
MY (1) | MY188000A (es) |
NO (1) | NO2799431T3 (es) |
NZ (1) | NZ627250A (es) |
PH (1) | PH12014501486A1 (es) |
PL (1) | PL2799431T3 (es) |
RU (1) | RU2576623C2 (es) |
SG (1) | SG11201403744YA (es) |
TW (1) | TWI546287B (es) |
WO (1) | WO2013099041A1 (es) |
ZA (1) | ZA201405503B (es) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2011323484B2 (en) * | 2010-11-01 | 2016-10-06 | Portola Pharmaceuticals, Inc. | Benzamides and nicotinamides as Syk modulators |
CA2932609A1 (en) | 2013-12-05 | 2015-06-11 | Pharmacyclics Llc | Inhibitors of bruton's tyrosine kinase |
KR101731624B1 (ko) * | 2014-07-01 | 2017-05-04 | 광주과학기술원 | 세포 리프로그래밍 유도용 조성물 |
JP6730309B2 (ja) | 2015-04-08 | 2020-07-29 | バイエル・クロップサイエンス・アクチェンゲゼルシャフト | 有害生物防除剤としての縮合二環式ヘテロ環誘導体及び中間体生成物 |
EP3896065A1 (de) | 2015-08-07 | 2021-10-20 | Bayer CropScience Aktiengesellschaft | 2-(het)aryl-substituierte kondensierte heterocyclen-derivate als schädlingsbekämpfungsmittel |
JP6472419B2 (ja) | 2015-09-30 | 2019-02-20 | 富士フイルム株式会社 | 芳香族化合物の製造方法 |
EP3368521B1 (de) | 2015-10-26 | 2021-09-01 | Bayer CropScience Aktiengesellschaft | Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel |
WO2017093180A1 (de) | 2015-12-01 | 2017-06-08 | Bayer Cropscience Aktiengesellschaft | Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel |
WO2017144341A1 (de) | 2016-02-23 | 2017-08-31 | Bayer Cropscience Aktiengesellschaft | Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel |
WO2017174414A1 (de) | 2016-04-05 | 2017-10-12 | Bayer Cropscience Aktiengesellschaft | Naphthalin-derivate als schädlingsbekämpfungsmittel |
EP3241830A1 (de) | 2016-05-04 | 2017-11-08 | Bayer CropScience Aktiengesellschaft | Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel |
CN106187899B (zh) * | 2016-06-28 | 2019-07-16 | 绍兴文理学院 | 一种氟代氮杂芳烃的合成方法 |
JP6967064B2 (ja) | 2016-07-19 | 2021-11-17 | バイエル・クロップサイエンス・アクチェンゲゼルシャフト | 有害生物防除剤としての縮合二環式ヘテロ環誘導体 |
JP6997420B2 (ja) | 2016-08-15 | 2022-01-17 | バイエル・クロップサイエンス・アクチェンゲゼルシャフト | 有害生物防除剤としての縮合二環式ヘテロ環誘導体 |
CN109963860A (zh) | 2016-09-19 | 2019-07-02 | 拜耳作物科学股份公司 | 吡唑并[1,5-a]吡啶衍生物及其作为农药的用途 |
WO2018138050A1 (de) | 2017-01-26 | 2018-08-02 | Bayer Aktiengesellschaft | Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel |
CN107056695A (zh) * | 2017-01-26 | 2017-08-18 | 青岛辰达生物科技有限公司 | 一种治疗胃癌药物阿帕替尼的合成方法 |
CN108689936B (zh) * | 2017-04-10 | 2021-09-10 | 西华大学 | 含氮取代基的吲唑类化合物及其作为ido抑制剂的用途 |
EP3305786A3 (de) | 2018-01-22 | 2018-07-25 | Bayer CropScience Aktiengesellschaft | Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel |
BR112020016926B1 (pt) | 2018-02-21 | 2022-08-30 | Bayer Aktiengesellschaft | Derivados heterocíclicos bicíclicos condensados, seu uso, formulação agroquímica, e método para controlar pragas animais |
CN109503473B (zh) * | 2019-01-07 | 2020-07-07 | 上海慧川生物医药科技有限公司 | 2-甲氧基-3-氨基-5-吡啶硼酸频哪醇酯及其中间体的合成方法 |
AU2020229979A1 (en) | 2019-02-26 | 2021-09-02 | Bayer Aktiengesellschaft | Fused bicyclic heterocycle derivatives as pesticides |
CN113727983A (zh) | 2019-02-26 | 2021-11-30 | 拜耳公司 | 作为害虫防治剂的稠合双环杂环衍生物 |
BR112021018168B1 (pt) | 2019-03-21 | 2023-11-28 | Onxeo | Composição farmacêutica, combinação e kit compreendendo uma molécula dbait e um inibidor de quinase para o tratamento de câncer |
CN110407744A (zh) * | 2019-08-13 | 2019-11-05 | 上海毕得医药科技有限公司 | 一种1-(4-氨基吡啶-2-基)乙酮的合成方法 |
JP2023500906A (ja) | 2019-11-08 | 2023-01-11 | インサーム(インスティテュ ナシオナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシェ メディカル) | キナーゼ阻害剤に対する獲得抵抗性を有するがんの処置方法 |
WO2021148581A1 (en) | 2020-01-22 | 2021-07-29 | Onxeo | Novel dbait molecule and its use |
WO2023119230A1 (en) | 2021-12-22 | 2023-06-29 | L'oreal | Coagulation pathway and nicotinamide-adenine dinucleotide pathway modulating compositions and methods of their use |
CN114230490A (zh) * | 2021-12-28 | 2022-03-25 | 乐威医药(江苏)股份有限公司 | 一种n-烷基化双胺的制备方法 |
WO2023129667A1 (en) | 2021-12-30 | 2023-07-06 | Biomea Fusion, Inc. | Pyrazine compounds as inhibitors of flt3 |
CN114349691A (zh) * | 2022-01-25 | 2022-04-15 | 阿里生物新材料(常州)有限公司 | 一种3,4-二氟-2-甲氧基-吡啶的合成方法 |
CN116535324A (zh) * | 2023-07-07 | 2023-08-04 | 广东嘉博制药有限公司 | 一种苏式构型盐酸甲氧明的制备方法 |
CN117285459B (zh) * | 2023-11-24 | 2024-02-27 | 上海美迪西生物医药股份有限公司 | 一种小分子激酶抑制剂化合物的制备方法 |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6133253A (en) | 1996-12-10 | 2000-10-17 | Abbott Laboratories | 3-Pyridyl enantiomers and their use as analgesics |
ATE401312T1 (de) * | 1997-12-15 | 2008-08-15 | Astellas Pharma Inc | Pyrimidin-5-carboxamid-derivate |
AU3364200A (en) | 1999-02-16 | 2000-09-04 | Basf Aktiengesellschaft | Process for the preparation of 6-(perfluoroalkyl)uracil compounds from carbamatecompounds |
US6797706B1 (en) | 1999-06-09 | 2004-09-28 | Yamanouchi Pharmaceutical Co., Ltd. | Heterocyclecarboxamide derivative |
AU5108000A (en) * | 1999-06-10 | 2001-01-02 | Yamanouchi Pharmaceutical Co., Ltd. | Novel nitrogen-contaiing heterocyclic derivatives or salts thereof |
KR20020083533A (ko) | 2000-03-31 | 2002-11-02 | 니뽄 신야쿠 가부시키가이샤 | 복소환 유도체 및 의약 |
JP2001302667A (ja) * | 2000-04-28 | 2001-10-31 | Bayer Ag | イミダゾピリミジン誘導体およびトリアゾロピリミジン誘導体 |
US20060079522A1 (en) | 2004-10-08 | 2006-04-13 | Marzabadi Mohammad R | Amino substituted aryloxybenzylpiperidine derivatives |
ES2375735T3 (es) | 2005-02-04 | 2012-03-05 | Astrazeneca Ab | Derivados de pirazolilaminopiridina útiles como inhibidores de quinasas. |
US8227455B2 (en) | 2005-04-18 | 2012-07-24 | Rigel Pharmaceuticals, Inc. | Methods of treating cell proliferative disorders |
KR101411695B1 (ko) | 2006-02-17 | 2014-07-03 | 리겔 파마슈티칼스, 인크. | 자가면역 질환의 치료 또는 예방을 위한 2,4-피리미딘디아민 화합물 |
CA2647543A1 (en) | 2006-03-29 | 2007-11-08 | Foldrx Pharmaceuticals, Inc. | Inhibition of alpha-synuclein toxicity |
JP2008013499A (ja) * | 2006-07-06 | 2008-01-24 | Sankyo Co Ltd | 5−シアノニコチンアミド誘導体 |
US20080020094A1 (en) | 2006-07-19 | 2008-01-24 | Lager Bernard G | Activated cranberry powder |
EP1932845A1 (en) | 2006-12-15 | 2008-06-18 | Bayer Schering Pharma Aktiengesellschaft | 3-H-pyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
TW200904421A (en) | 2007-05-03 | 2009-02-01 | Astellas Pharma Inc | New compounds |
WO2009026107A1 (en) | 2007-08-17 | 2009-02-26 | Portola Pharmaceuticals, Inc. | Protein kinase inhibitors |
AR068509A1 (es) | 2007-09-19 | 2009-11-18 | Jerini Ag | Antagosnistas del receptor de bradiquinina b1 |
US20090076275A1 (en) | 2007-09-19 | 2009-03-19 | David Robert Bolin | Diacylglycerol acyltransferase inhibitors |
EP2070929A1 (en) | 2007-12-11 | 2009-06-17 | Bayer Schering Pharma Aktiengesellschaft | Alkynylaryl compounds and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
WO2009090548A2 (en) | 2008-01-17 | 2009-07-23 | Glenmark Pharmaceuticals, S.A. | 3-azabicyclo [3.1.0] hexane derivatives as vanilloid receptor ligands |
KR20170051521A (ko) | 2008-04-16 | 2017-05-11 | 포톨라 파마슈티컬스, 인코포레이티드 | syk 또는 JAK 키나제 억제제로서의 2,6-디아미노-피리미딘-5-일-카르복스아미드 |
EA024109B1 (ru) | 2008-04-16 | 2016-08-31 | Портола Фармасьютиклз, Инк. | Ингибиторы протеинкиназ |
WO2009131687A2 (en) | 2008-04-22 | 2009-10-29 | Portola Pharmaceuticals, Inc. | Inhibitors of protein kinases |
US8658159B2 (en) | 2008-06-30 | 2014-02-25 | Versitech Limited | Method to induce and expand therapeutic alloantigen-specific human regulatory T cells in large-scale |
EP2361902A4 (en) | 2008-11-21 | 2012-04-25 | Astellas Pharma Inc | 4,6-DIAMINONICOTINSÄUREAMIDVERBINDUNG |
AU2010219097A1 (en) | 2009-01-13 | 2011-08-04 | Glaxo Group Limited | Pyrimidinecarboxamide derivatives as inhibitors of SYK kinase |
JP5651681B2 (ja) | 2009-04-03 | 2015-01-14 | 大日本住友製薬株式会社 | 代謝型グルタミン酸受容体5介在障害の治療のための化合物、およびその使用方法 |
JP2012529535A (ja) * | 2009-06-12 | 2012-11-22 | ブリストル−マイヤーズ スクイブ カンパニー | キナーゼモジュレーターとして有用なニコチンアミド化合物 |
MX2012015023A (es) * | 2010-06-30 | 2013-04-03 | Fujifilm Corp | Derivado novedoso de nicotinamida o sal del mismo. |
AU2011323484B2 (en) * | 2010-11-01 | 2016-10-06 | Portola Pharmaceuticals, Inc. | Benzamides and nicotinamides as Syk modulators |
-
2011
- 2011-12-28 TW TW100149162A patent/TWI546287B/zh not_active IP Right Cessation
- 2011-12-28 RU RU2014131011/04A patent/RU2576623C2/ru active
- 2011-12-28 DK DK11878563.3T patent/DK2799431T3/en active
- 2011-12-28 CA CA2861202A patent/CA2861202C/en not_active Expired - Fee Related
- 2011-12-28 MY MYPI2014001969A patent/MY188000A/en unknown
- 2011-12-28 SG SG11201403744YA patent/SG11201403744YA/en unknown
- 2011-12-28 MX MX2014007785A patent/MX362940B/es active IP Right Grant
- 2011-12-28 EP EP11878563.3A patent/EP2799431B1/en active Active
- 2011-12-28 BR BR112014016328A patent/BR112014016328A8/pt not_active Application Discontinuation
- 2011-12-28 ES ES11878563.3T patent/ES2661444T3/es active Active
- 2011-12-28 WO PCT/JP2011/080597 patent/WO2013099041A1/ja active Application Filing
- 2011-12-28 NZ NZ627250A patent/NZ627250A/en not_active IP Right Cessation
- 2011-12-28 JP JP2011288205A patent/JP5868168B2/ja active Active
- 2011-12-28 NO NO11878563A patent/NO2799431T3/no unknown
- 2011-12-28 PL PL11878563T patent/PL2799431T3/pl unknown
- 2011-12-28 CN CN201180076091.1A patent/CN104024226B/zh not_active Expired - Fee Related
- 2011-12-28 KR KR1020147020514A patent/KR101744607B1/ko active IP Right Grant
-
2014
- 2014-06-26 PH PH12014501486A patent/PH12014501486A1/en unknown
- 2014-06-26 IL IL233385A patent/IL233385B/en active IP Right Grant
- 2014-06-27 US US14/317,001 patent/US9051310B2/en not_active Expired - Fee Related
- 2014-07-25 ZA ZA2014/05503A patent/ZA201405503B/en unknown
-
2016
- 2016-05-06 AU AU2016202949A patent/AU2016202949A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12014501486A1 (en) | Novel nicotinamide derivative or salt thereof | |
MX344276B (es) | Compuesto de piperidina novedoso o sal del mismo. | |
PH12014501719A1 (en) | Pyridone derivatives | |
EA201070994A1 (ru) | Конденсированное гетероциклическое производное и его применение | |
PH12015502038A1 (en) | 2,3-disubstituted 1 -acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors | |
MX2009004920A (es) | Nuevos derivados de aminopirimidina como inhibidores de plk1. | |
MY177250A (en) | Novel nicotinamide derivative or salt thereof | |
SMT201300085B (it) | Composti di pirrolo | |
TW200732323A (en) | Organic compounds | |
MY172862A (en) | Dispiropyrrolidine derivatives | |
MY166970A (en) | Subtituted pyrrolo [2,3-h][1,6]naphthyridines and compositions thereof as jak inhibitors | |
CA2864222A1 (en) | Cycloalkane derivative | |
RS54506B1 (en) | PICOLINAMIDE DERIVATIVES AS KINASE INHIBITORS | |
MX336268B (es) | Compuesto de amidina o sal del mismo. | |
MX2014000452A (es) | Derivados de azabencimiazol que tiene actividad activadora de la proteina cinasa activada monofosfato de denosina (ampk). | |
MX2013004407A (es) | Derivado de piridina y agente medicinal. | |
MY153910A (en) | BICYCLIC y-AMINO ACID DERIVATIVE | |
MX2013007490A (es) | Derivados de aminodihidrotiazina fusionada. | |
MX2009007713A (es) | Derivados de piridazina, procedimientos para su preparacion y su uso como fungicidas. | |
EA201170224A1 (ru) | Новые производные имидазо[1,2-a]пиримидинов, способ их получения, их применение в качестве лекарственных средств, фармацевтические композиции и новое применение, в частности, в качестве ингибиторов мет | |
EA201390374A1 (ru) | Гетероциклические соединения для лечения или профилактики расстройств, вызываемых ослабленной нейротрансмиссией серотонина, норэпинефрина или допамина | |
NZ595890A (en) | Pyrazole compound | |
RS54514B1 (en) | HETEROCYCLIC UNITS AS HISTAMINE H3 LEGANDS OF THE RECEPTOR | |
JO3082B1 (ar) | مشتق بيروليدين-3- يل حمض خليك | |
UA116877C2 (uk) | Сполука з антибактеріальною і/абопротивірусною активністю |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |